{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:03:11Z","timestamp":1782975791838,"version":"3.54.5"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Osteonecrosis (ON) is a prevalent and severe complication in patients with systemic lupus erythematosus (SLE). However, the etiology and mechanism of SLE-ON have not been fully elucidated. This study aims to investigate the factors related to SLE-ON and provide a basis for early prevention and control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive search of relevant literatures was conducted from PubMed, Ovid Medline, Web of Science, Embase, Cochrane Library, CNKI, Wanfang Data, and VIP Information databases up to 31 October 2025. According to the inclusion and exclusion criteria, 3,051 studies were examined, and quality of each study was assessed using the Newcastle\u2013Ottawa scale (NOS). Meta-analysis methods discussed the association of the factors related to SLE-ON.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 64 studies were finally included in the meta-analysis. For clinical features, factors such as neuropsychiatric lupus (OR\u00a0=\u00a01.652), hyperlipidemia (OR\u00a0=\u00a01.358), oral ulcers (OR\u00a0=\u00a01.319), pleuritis (OR\u00a0=\u00a02.225), malar rash (OR\u00a0=\u00a01.311), vasculitis (OR\u00a0=\u00a02.638), serositis (OR\u00a0=\u00a01.514), hematologic involvement (OR\u00a0=\u00a01.190), Reynaud\u2019s phenomenon (OR\u00a0=\u00a01.604), thrombophlebitis (OR\u00a0=\u00a01.856), and arthritis (OR\u00a0=\u00a01.256) were positively related to SLE-ON risk. For laboratory features, proteinuria (OR\u00a0=\u00a01.635), antiphospholipid antibody (OR\u00a0=\u00a01.450), elevated ESR (OR\u00a0=\u00a01.623), leukopenia (OR\u00a0=\u00a01.317), and ACL (OR\u00a0=\u00a01.657) were positively related to SLE-ON risk as well. Interestingly, the anti-SSA antibody (OR\u00a0=\u00a00.805) and anti-SSB antibody (OR\u00a0=\u00a00.764) were negatively related to SLE-ON susceptibility. Usage of cyclophosphamide (OR\u00a0=\u00a01.869) and steroid pulse therapy (OR\u00a0=\u00a01.829) was positively correlated with occurrence of SLE-ON. Furthermore, younger age (SMD=\u22120.175) and the age at onset (SMD=\u22120.426) significantly related to developing of SLE-ON.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A total of 32 factors including clinical, laboratory features, drug usage, and basic information in SLE patients were related to SLE complicated with osteonecrosis. Of note, the association between cyclophosphamide\/steroid pulse therapy and SLE-ON risk may be confounded by underlying disease severity, so these results should be interpreted cautiously. Targeted monitoring and intervention of these modifiable risk factors, especially optimized steroid pulse therapy and cyclophosphamide use and early osteoporosis screening, combined with risk stratification based on anti-SSA\/SSB antibody status, may help reduce SLE-ON risk and improve clinical management of SLE patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1679237","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:35:57Z","timestamp":1782970557000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Meta-analysis of factors for osteonecrosis in systemic lupus erythematosus: integration of comprehensive literatures and multicenter databases"],"prefix":"10.3389","volume":"17","author":[{"given":"Rui-Cen","family":"Li","sequence":"first","affiliation":[{"name":"Health Management Center, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Chong","family":"Su","sequence":"additional","affiliation":[{"name":"Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic Diseases, Affiliated Minda Hospital of Hubei Minzu University","place":["Enshi, Hubei, China"]},{"name":"Department of Rheumatology and Immunology, Affiliated Minda Hospital of Hubei Minzu University","place":["Enshi, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Fang","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Affiliated Hospital, Southwest Medical University","place":["Luzhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Dong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Evidence-Based Medicine, School of Public Health, Southwest Medical University","place":["Luzhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Evidence-Based Medicine, School of Public Health, Southwest Medical University","place":["Luzhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1305590","article-title":"Th1-related transcription factors and cytokines in systemic lupus erythematosus","volume":"14","author":"Tang","year":"2023","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12178-015-9277-8","article-title":"Pathophysiology and risk factors for osteonecrosis","volume":"8","author":"Shah","year":"2015","journal-title":"Curr Rev Musculoskelet Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jot.2021.07.004","article-title":"Evolutionary course of the femoral head osteonecrosis: Histopathological-radiologic characteristics and clinical staging systems","volume":"32","author":"Chen","year":"2022","journal-title":"J Orthop Transl"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2022.100168","article-title":"Steroid-induced osteonecrosis","volume":"5","author":"Motta","year":"2022","journal-title":"J\u00a0Transl Autoimmun"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.RVW.20.00142","article-title":"Femoral head osteonecrosis in systemic lupus erythematosus: Total hip arthroplasty outcomes and considerations","volume":"9","author":"Trent","year":"2021","journal-title":"JBJS Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jot.2019.12.004","article-title":"Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version)","volume":"21","author":"Zhao","year":"2020","journal-title":"J\u00a0Orthop Transl"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.52600\/2763-583X.bjcr.2025.5.1.bjcr32","article-title":"Freiberg's infraction in the context of systemic lupus erythematosus","volume":"5","author":"G\u00f6kten","year":"2025","journal-title":"Braz J Case Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24541","article-title":"Predictors of osteonecrosis in systemic lupus erythematosus: A prospective cohort study","volume":"74","author":"Kallas","year":"2022","journal-title":"Arthritis Care Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1381035","article-title":"Risk factors and prediction model for osteonecrosis of the femoral head in female systemic lupus erythematosus","volume":"15","author":"Xu","year":"2024","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102992","article-title":"Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management","volume":"21","author":"Zheng","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3906\/sag-1908-182","article-title":"Avascular\u00a0necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid","volume":"50","author":"Do\u011fan","year":"2020","journal-title":"Turk J Med Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/09612033211021166","article-title":"Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study","volume":"30","author":"Long","year":"2021","journal-title":"Lupus"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318784648","article-title":"Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus","volume":"27","author":"Kwon","year":"2018","journal-title":"Lupus"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248845","article-title":"Risk factors for symptomatic avascular necrosis (AVN) in a multi-ethnic systemic lupus erythematosus (SLE) cohort","volume":"16","author":"Shaharir","year":"2021","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-eular.7434","article-title":"Associated factors and prevalence of osteonecrosis in a cohort study in patients with systemic lupus erythematosus (SLE) from Hospital del Mar\/Parc de Salut Mar","volume":"78","author":"Vilchez-Oya","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2174\/1573397117666210907124242","article-title":"Predictors of avascular necrosis in a cohort of Egyptian systemic lupus erythematosus patients: Retrospective two centers study","volume":"18","author":"Moghazy","year":"2022","journal-title":"Curr Rheumatol Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13075-023-03061-3","article-title":"Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII","volume":"25","author":"Cheng","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.847875","article-title":"Anti-RNP antibody: A potential novel predictor for osteonecrosis in systemic lupus erythematosus","volume":"9","author":"Xiong","year":"2022","journal-title":"Front Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key365","article-title":"Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosus","volume":"58","author":"Hisada","year":"2019","journal-title":"Rheumatology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316676384","article-title":"Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus","volume":"26","author":"Tse","year":"2017","journal-title":"Lupus"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.9790\/0853-150810130133","article-title":"Avascular necrosis of bone in patients with systemic lupus erythematosus","volume":"15","author":"Hassan Jokar","year":"2016","journal-title":"IOSR J Dent Med Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3075-y","article-title":"High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosus","volume":"34","author":"Kuroda","year":"2015","journal-title":"Clin Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1191\/096120398678919732","article-title":"Association of osteonecrosis in systemic lupus erythematosus with abnormalities of fibrinolysis","volume":"7","author":"Sheikh","year":"1998","journal-title":"Lupus"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1194-y","article-title":"Investigation of occurrence of osteonecrosis of the femoral head after increasing corticosteroids in patients with recurring systemic lupus erythematosus","volume":"30","author":"Sekiya","year":"2010","journal-title":"Rheumatol Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/096120339400300108","article-title":"Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies","volume":"3","author":"Migliaresi","year":"1994","journal-title":"Lupus"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3109\/03009749709065679","article-title":"Avascular necrosis of bone in systemic lupus erythematosus. The predictive role of precipitating autoantibodies","volume":"26","author":"Watanabe","year":"1997","journal-title":"Scand J Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/rheumatology\/37.8.895","article-title":"Risk factors for avascular bone necrosis in systemic lupus erythematosus","volume":"37","author":"Mok","year":"1998","journal-title":"Br J Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.53347\/rid-29563","article-title":"Predictors of avascular necrosis of the hip in Emiratis patients with systemic lupus erythematosus","volume":"17","author":"Al Saleh","year":"2010","journal-title":"Egypt J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1177\/096120339200100610","article-title":"High-dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus","volume":"1","author":"Massardo","year":"1992","journal-title":"Lupus"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-3147-3","article-title":"Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study","volume":"35","author":"Joo","year":"2015","journal-title":"Rheumatol Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150464","article-title":"Risk factors for symptomatic avascular necrosis in childhood-onset systemic lupus erythematosus","volume":"42","author":"Yang","year":"2015","journal-title":"J Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00003086-199204000-00011","article-title":"Risk factors of avascular necrosis of the femoral head in patients with systemic lupus erythematosus under high-dose corticosteroid therapy","volume":"277","author":"Ono","year":"1992","journal-title":"Clin Orthop Relat Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/ard.38.5.413","article-title":"Clinical and radiological features of osteonecrosis in systemic lupus erythematosus","volume":"38","author":"Griffiths","year":"1979","journal-title":"Ann Rheum Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.040428","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study","volume":"65","author":"Calvo-Al\u00e9n","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2103oa","article-title":"Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI","volume":"14","author":"Nagasawa","year":"2005","journal-title":"Lupus"},{"key":"B38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejr.2010.09.002","article-title":"Avascular necrosis of bone in systemic lupus erythematosus","volume":"33","author":"Ghaleb","year":"2011","journal-title":"Egypt Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2008.00349.x","article-title":"Risk factors for avascular necrosis among Filipino patients with systemic lupus erythematosus","volume":"11","author":"Hamijoyo","year":"2008","journal-title":"Int J Rheum Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.12.1145","article-title":"Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment","volume":"60","author":"Oinuma","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/ard.48.8.672","article-title":"Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities","volume":"48","author":"Nagasawa","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"B42","article-title":"Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a reevaluation","volume":"16","author":"Weiner","year":"1989","journal-title":"J Rheumatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/0961203313512880","article-title":"Osteonecrosis of the hip in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome","volume":"23","author":"Lee","year":"2014","journal-title":"Lupus"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2014.987366","article-title":"Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: A retrospective case-control study","volume":"25","author":"Faezi","year":"2015","journal-title":"Mod Rheumatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307076771","article-title":"Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus","volume":"16","author":"Fialho","year":"2007","journal-title":"Lupus"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1597-9","article-title":"Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus","volume":"32","author":"Sayarlioglu","year":"2012","journal-title":"Rheumatol Int"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1177\/0961203306075771","article-title":"The role of non-corticosteroid related factors in osteonecrosis (ON) in systemic lupus erythematosus: a nested case-control study of inception patients","volume":"16","author":"Prasad","year":"2007","journal-title":"Lupus"},{"key":"B48","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/0002-9343(85)90057-9","article-title":"Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus","volume":"79","author":"Zizic","year":"1985","journal-title":"Am J Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181ba3423","article-title":"Factors associated with osteonecrosis in Thai lupus patients A case control study","volume":"15","author":"Uea-areewongsa","year":"2009","journal-title":"JCR-J Clin Rheumatol"},{"key":"B50","article-title":"Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus","volume":"28","author":"Gladman","year":"2001","journal-title":"J Rheumatol"},{"key":"B51","article-title":"Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients","volume":"30","author":"Kunyakham","year":"2012","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B52","article-title":"Risk factors for osteonecrosis in systemic lupus erythematosus","volume":"24","author":"Mont","year":"1997","journal-title":"J Rheumatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/ard.35.3.227","article-title":"Avascular necrosis in SLE. An apparent predilection for young patients","volume":"35","author":"Smith","year":"1976","journal-title":"Ann Rheum Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1004-437X.2022.21.019","article-title":"Correlation between systemic lupus erythematosus complicated with osteonecrosis and C-reactive protein, immunoglobulin G and hematocrit","volume":"31","author":"Liu","year":"2022","journal-title":"Henan Med Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2022.06.005","article-title":"Risk factors for osteonecrosis of the femoral head in patients with systemic lupus erythematosus","volume":"14","author":"Li","year":"2008","journal-title":"Chin J Osteoporos"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1001-9030.2010.12.060","article-title":"Risk factor of osteonecrosis of the femoral head in patients with systemic lupus erythematosus","volume":"27","author":"Qi","year":"2010","journal-title":"Chin J Exp Surg"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-23488-0_12","article-title":"Risk factors for osteonecrosis of the femoral head in patients with systemic lupus erythematosus","volume":"49","author":"Xuan","year":"2011","journal-title":"J Shandong Univ Health Sci"},{"key":"B58","article-title":"Clinical study on avascular necrosis of the femoral head in patients with systemic lupus erythematosus (plus clinical studies of 10 cases)","volume":"18","author":"Shen","year":"2012","journal-title":"Med Recapitulate"},{"key":"B59","article-title":"Risk factors of systemic lupus erythematosus patients with aseptic necrosis of the femoral head","volume":"17","author":"Shi","year":"2013","journal-title":"J Clin Med Pract"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1007-7480.2014.03.008","article-title":"Clinical features and factors associated with knee osteoneerosis in patients with systemic lupus erythematosus","volume":"18","author":"Wu","year":"2014","journal-title":"Chin J Rheumato"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/b978-1-4377-1720-4.00309-5","article-title":"Clinical study on the related factors of aseptic osteonecrosis of the femoral head complicating systemic lupus erythematosus","volume":"22","author":"Lin","year":"2014","journal-title":"J\u00a0Front Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.12056\/j.issn.1006-2785.2018.40.22.2018-1972","article-title":"Analysis of clinical related factors of osteonecrosis of the femoral head in patients with systemic lupus erythematosus","volume":"40","author":"Wang","year":"2018","journal-title":"Zhejiang Med J"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112138-20200916-00818","article-title":"Clinical characteristics and risk factors in 118 patients with systemic lupus erythematosus and osteonecrosis","volume":"60","author":"Li","year":"2021","journal-title":"Chin J Intern Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.16766\/j.cnki.issn.1674-4152.003495","article-title":"Influencing factors analysis of systemic lupus erythematosus with osteonecrosis","volume":"22","author":"Lei","year":"2024","journal-title":"Chin J Gen Pract"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.13457\/j.cnki.jncm.2008.08.072","article-title":"Pathogenesis of systemic lupus erythematosus complicated with avascular necrosis of femoral head","volume":"40","author":"Zhang","year":"2008","journal-title":"J New Chin Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1006-5725.2011.07.039","article-title":"Analysis of related factors of systemic lupus erythematosus complicated with avascular necrosis of the femoral head","volume":"27","author":"Liu","year":"2011","journal-title":"J Pract Med"},{"key":"B67","article-title":"An analysis of 40 systemic lupus erythematosus patients with avascular necrosis of bone in Xinjiang area","volume":"7","author":"Li","year":"2014","journal-title":"J Pract Dermatol"},{"key":"B68","article-title":"Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus","volume":"3","author":"Tang","year":"1999","journal-title":"Chin J Rheumatol"},{"key":"B69","article-title":"Research of osteonecrosis in patients with systemic lupus erythematosus","volume":"9","author":"Shen","year":"2005","journal-title":"Chin J Rheumatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0961203317711012","article-title":"Osteonecrosis in SLE: prevalence, patterns, outcomes and predictors","volume":"27","author":"Gladman","year":"2018","journal-title":"Lupus"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211002677","article-title":"Associations between glucocorticoids, antiphospholipid antibodies and femur head necrosis in patients with SLE: a directed acyclic graph-based multicentre study","volume":"13","author":"Chen","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0578-1426.2009.11.009","article-title":"A clinical study of femoral head osteonecrosis in patients with systemic lupus erythematosus","volume":"48","author":"Wang","year":"2009","journal-title":"Chin J Integr Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046163","article-title":"Relationship between osteonecrosis and antiphospholipid antibodies in patients with systemic lupus erythematosus: a systematic review protocol","volume":"11","author":"Wei","year":"2021","journal-title":"BMJ Open"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead016","article-title":"Genetics of osteonecrosis in children and adults with systemic lupus erythematosus","volume":"62","author":"Webber","year":"2023","journal-title":"Rheumatology"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1288234","article-title":"The association of an elevated Th\/Ts ratio and lupus anticoagulant with symptomatic osteonecrosis in systemic lupus erythematosus patients","volume":"15","author":"Hou","year":"2024","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-014-9917-y","article-title":"The risk factors of avascular necrosis in patients with systemic lupus erythematosus: a meta-analysis","volume":"37","author":"Zhu","year":"2014","journal-title":"Inflammation"},{"key":"B77","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10067-017-3820-5","article-title":"Systemic lupus erythematosus patients with high disease activity are associated with accelerated incidence of osteonecrosis: a systematic review and meta-analysis","volume":"37","author":"Zhang","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158364","article-title":"Statins neuromuscular adverse effects","volume":"23","author":"Attardo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B79","article-title":"A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors","volume":"35","author":"Nevskaya","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-023-01755-7","article-title":"Lupus nephritis or not? A simple and clinically friendly machine learning pipeline to help diagnosis of lupus nephritis","volume":"72","author":"Wang","year":"2023","journal-title":"Inflammation Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28818","article-title":"Association between TL1A gene polymorphisms and systemic lupus erythematosus in a Chinese Han population","volume":"234","author":"Xu","year":"2019","journal-title":"J Cell Physiol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2023.101893","article-title":"Systemic lupus erythematosus and damage: What has changed over the past 20 years","volume":"37","author":"Munoz-Grajales","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1258\/ar.2012.120508","article-title":"Quantitative assessment of microcirculation and diffusion in the bone marrow of osteoporotic rats using VCT, DCE-MRI, DW-MRI, and histology","volume":"54","author":"Liu","year":"2013","journal-title":"Acta Radiol"},{"key":"B84","article-title":"Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus","volume":"20","author":"Asherson","year":"1993","journal-title":"J Rheumatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.526","article-title":"Glucocorticoid-induced osteonecrosis in systemic lupus erythematosus patients","volume":"11","author":"Kaneko","year":"2021","journal-title":"Clin Transl Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key009","article-title":"Transitional changes in the incidence of osteonecrosis in systemic lupus erythematosus patients: focus on immunosuppressant agents and glucocorticoids","volume":"57","author":"Nawata","year":"2018","journal-title":"Rheumatology"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1269168","article-title":"Hydroxychloroquine in systemic lupus erythematosus (SLE)","volume":"16","author":"Ponticelli","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000743","article-title":"Update on antimalarials and systemic lupus erythematosus","volume":"32","author":"Ruiz-Irastorza","year":"2020","journal-title":"Curr Opin Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1679237\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:36:08Z","timestamp":1782970568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1679237\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":88,"alternative-id":["10.3389\/fimmu.2026.1679237"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1679237","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"article-number":"1679237"}}